The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Necrotizing Ulcerative Gingivitis (NUG) Treatment-Global Market Insights and Sales Trends 2024
Synopsis
Treatment of ANUG is by removal of dead gum tissue and antibiotics (usually metronidazole) in the acute phase, and improving oral hygiene to prevent recurrence. Although the condition has a rapid onset and is debilitating, it usually resolves quickly and does no serious harm.
The global Necrotizing Ulcerative Gingivitis (NUG) Treatment market size is expected to reach US$ 10530 million by 2029, growing at a CAGR of 7.5% from 2023 to 2029. The market is mainly driven by the significant applications of Necrotizing Ulcerative Gingivitis (NUG) Treatment in various end use industries. The expanding demands from the Hospitals, Homecare, Pharmacies and Others, are propelling Necrotizing Ulcerative Gingivitis (NUG) Treatment market. Medication, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Surgery segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Necrotizing Ulcerative Gingivitis (NUG) Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Necrotizing Ulcerative Gingivitis (NUG) Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Necrotizing Ulcerative Gingivitis (NUG) Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Necrotizing Ulcerative Gingivitis (NUG) Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Necrotizing Ulcerative Gingivitis (NUG) Treatment covered in this report include Novartis, Teva Pharmaceutical, Mylan, Sanofi, GlaxoSmithKline, Merck, Otsuka Pharmaceutical, Abbott Laboratories and Eli Lilly and Company, etc.
The global Necrotizing Ulcerative Gingivitis (NUG) Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Teva Pharmaceutical
Mylan
Sanofi
GlaxoSmithKline
Merck
Otsuka Pharmaceutical
Abbott Laboratories
Eli Lilly and Company
Hindustan Antibiotics
Global Necrotizing Ulcerative Gingivitis (NUG) Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Necrotizing Ulcerative Gingivitis (NUG) Treatment market, Segment by Type:
Medication
Surgery
Global Necrotizing Ulcerative Gingivitis (NUG) Treatment market, by Application
Hospitals
Homecare
Pharmacies
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Necrotizing Ulcerative Gingivitis (NUG) Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Treatment of ANUG is by removal of dead gum tissue and antibiotics (usually metronidazole) in the acute phase, and improving oral hygiene to prevent recurrence. Although the condition has a rapid onset and is debilitating, it usually resolves quickly and does no serious harm.
The global Necrotizing Ulcerative Gingivitis (NUG) Treatment market size is expected to reach US$ 10530 million by 2029, growing at a CAGR of 7.5% from 2023 to 2029. The market is mainly driven by the significant applications of Necrotizing Ulcerative Gingivitis (NUG) Treatment in various end use industries. The expanding demands from the Hospitals, Homecare, Pharmacies and Others, are propelling Necrotizing Ulcerative Gingivitis (NUG) Treatment market. Medication, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Surgery segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Necrotizing Ulcerative Gingivitis (NUG) Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Necrotizing Ulcerative Gingivitis (NUG) Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Necrotizing Ulcerative Gingivitis (NUG) Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Necrotizing Ulcerative Gingivitis (NUG) Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Necrotizing Ulcerative Gingivitis (NUG) Treatment covered in this report include Novartis, Teva Pharmaceutical, Mylan, Sanofi, GlaxoSmithKline, Merck, Otsuka Pharmaceutical, Abbott Laboratories and Eli Lilly and Company, etc.
The global Necrotizing Ulcerative Gingivitis (NUG) Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Teva Pharmaceutical
Mylan
Sanofi
GlaxoSmithKline
Merck
Otsuka Pharmaceutical
Abbott Laboratories
Eli Lilly and Company
Hindustan Antibiotics
Global Necrotizing Ulcerative Gingivitis (NUG) Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Necrotizing Ulcerative Gingivitis (NUG) Treatment market, Segment by Type:
Medication
Surgery
Global Necrotizing Ulcerative Gingivitis (NUG) Treatment market, by Application
Hospitals
Homecare
Pharmacies
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Necrotizing Ulcerative Gingivitis (NUG) Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Necrotizing Ulcerative Gingivitis (NUG) Treatment
1.1 Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Overview
1.1.1 Necrotizing Ulcerative Gingivitis (NUG) Treatment Product Scope
1.1.2 Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Status and Outlook
1.2 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Region (2018-2029)
1.4 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Historic Market Size by Region (2018-2023)
1.5 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029)
1.6.1 North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029)
1.6.2 Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029)
1.6.4 Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029)
2 Necrotizing Ulcerative Gingivitis (NUG) Treatment Market by Type
2.1 Introduction
2.1.1 Medication
2.1.2 Surgery
2.2 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Breakdown by Type (2018-2029)
3 Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Homecare
3.1.3 Pharmacies
3.1.4 Others
3.2 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Breakdown by Application (2018-2029)
4 Necrotizing Ulcerative Gingivitis (NUG) Treatment Competition Analysis by Players
4.1 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment as of 2022)
4.3 Date of Key Players Enter into Necrotizing Ulcerative Gingivitis (NUG) Treatment Market
4.4 Global Top Players Necrotizing Ulcerative Gingivitis (NUG) Treatment Headquarters and Area Served
4.5 Key Players Necrotizing Ulcerative Gingivitis (NUG) Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Novartis
5.1.1 Novartis Profile
5.1.2 Novartis Main Business
5.1.3 Novartis Necrotizing Ulcerative Gingivitis (NUG) Treatment Products, Services and Solutions
5.1.4 Novartis Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Novartis Recent Developments
5.2 Teva Pharmaceutical
5.2.1 Teva Pharmaceutical Profile
5.2.2 Teva Pharmaceutical Main Business
5.2.3 Teva Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Treatment Products, Services and Solutions
5.2.4 Teva Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Teva Pharmaceutical Recent Developments
5.3 Mylan
5.3.1 Mylan Profile
5.3.2 Mylan Main Business
5.3.3 Mylan Necrotizing Ulcerative Gingivitis (NUG) Treatment Products, Services and Solutions
5.3.4 Mylan Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Sanofi Recent Developments
5.4 Sanofi
5.4.1 Sanofi Profile
5.4.2 Sanofi Main Business
5.4.3 Sanofi Necrotizing Ulcerative Gingivitis (NUG) Treatment Products, Services and Solutions
5.4.4 Sanofi Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Sanofi Recent Developments
5.5 GlaxoSmithKline
5.5.1 GlaxoSmithKline Profile
5.5.2 GlaxoSmithKline Main Business
5.5.3 GlaxoSmithKline Necrotizing Ulcerative Gingivitis (NUG) Treatment Products, Services and Solutions
5.5.4 GlaxoSmithKline Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 GlaxoSmithKline Recent Developments
5.6 Merck
5.6.1 Merck Profile
5.6.2 Merck Main Business
5.6.3 Merck Necrotizing Ulcerative Gingivitis (NUG) Treatment Products, Services and Solutions
5.6.4 Merck Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Merck Recent Developments
5.7 Otsuka Pharmaceutical
5.7.1 Otsuka Pharmaceutical Profile
5.7.2 Otsuka Pharmaceutical Main Business
5.7.3 Otsuka Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Treatment Products, Services and Solutions
5.7.4 Otsuka Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Otsuka Pharmaceutical Recent Developments
5.8 Abbott Laboratories
5.8.1 Abbott Laboratories Profile
5.8.2 Abbott Laboratories Main Business
5.8.3 Abbott Laboratories Necrotizing Ulcerative Gingivitis (NUG) Treatment Products, Services and Solutions
5.8.4 Abbott Laboratories Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Abbott Laboratories Recent Developments
5.9 Eli Lilly and Company
5.9.1 Eli Lilly and Company Profile
5.9.2 Eli Lilly and Company Main Business
5.9.3 Eli Lilly and Company Necrotizing Ulcerative Gingivitis (NUG) Treatment Products, Services and Solutions
5.9.4 Eli Lilly and Company Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Eli Lilly and Company Recent Developments
5.10 Hindustan Antibiotics
5.10.1 Hindustan Antibiotics Profile
5.10.2 Hindustan Antibiotics Main Business
5.10.3 Hindustan Antibiotics Necrotizing Ulcerative Gingivitis (NUG) Treatment Products, Services and Solutions
5.10.4 Hindustan Antibiotics Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 Hindustan Antibiotics Recent Developments
6 North America
6.1 North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Dynamics
11.1 Necrotizing Ulcerative Gingivitis (NUG) Treatment Industry Trends
11.2 Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Drivers
11.3 Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Challenges
11.4 Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
